The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pomalidomide (POM), bortezomib, and low‐dose dexamethasone (PVd) vs bortezomib and low-dose dexamethasone (Vd) in lenalidomide (LEN)-exposed patients (pts) with relapsed or refractory multiple myeloma (RRMM): Phase 3 OPTIMISMM trial.
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Takeda
Research Funding - Celgene; Takeda
 
Albert Oriol Rocafiguera
Honoraria - Amgen; Janssen; Takeda
Consulting or Advisory Role - Amgen; Janssen; Takeda
Speakers' Bureau - Amgen; Janssen
 
Meral Beksac
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Novartis; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Janssen-Cilag
 
Anna Marina Liberati
No Relationships to Disclose
 
Monica Galli
Honoraria - Celgene; Janssen; Sigma-Tau
Consulting or Advisory Role - Celgene; Janssen; Sigma-Tau
Speakers' Bureau - Celgene; Janssen; Sigma-Tau
 
Fredrik Schjesvold
Honoraria - Abbvie; Amgen; Celgene; Janssen; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Pfizer; Takeda
Research Funding - Amgen; Janssen
Travel, Accommodations, Expenses - Amgen; Celgene
 
Jindriska Lindsay
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Takeda
 
Katja Weisel
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Sanofi; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Sanofi; Takeda
Other Relationship - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Sanofi; Takeda
 
Darell White
Honoraria - Amgen; Celgene; Janssen; Takeda
Other Relationship - Celgene; Janssen; Takeda
 
Thierry Facon
Consulting or Advisory Role - Celgene; Janssen
Speakers' Bureau - Celgene; Janssen
Travel, Accommodations, Expenses - Celgene; Janssen
 
Jesus San-Miguel
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; MSD; Novartis; Roche; Sanofi; Takeda
 
Kazutaka Sunami
Honoraria - Bristol-Myers Squibb; Celgene; Ono Pharmaceutical
Research Funding - Abbvie; Bristol-Myers Squibb; Celgene; MSD; Sanofi; Takeda
 
Peter O'Gorman
Honoraria - Janssen
Research Funding - Celgene; Janssen
Expert Testimony - Takeda
Travel, Accommodations, Expenses - Pfizer
 
Pieter Sonneveld
Honoraria - Amgen; Celgene; Janssen; Karyopharm Therapeutics
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Skyline Diagnostics
 
Xin Yu
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Thomas Doerr
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Amine Bensmaine
Employment - Celgene
 
Mohamed H. Zaki
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Kenneth Carl Anderson
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Millennium
Patents, Royalties, Other Intellectual Property - C4 Therapeutics; Oncopep
 
Meletios A. Dimopoulos
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genesis Pharmaceuticals; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
Research Funding - Amgen (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Amgen; Genesis Pharmaceuticals; Janssen-Ortho